Hepatic arterial infusion of autologous gamma/delta T cell for advanced hepatocellular carcinoma
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2016
At a glance
- Drugs T-lymphocyte cell therapy (Primary) ; Zoledronic acid
- Indications Liver cancer
- Focus Adverse reactions
- 29 Sep 2016 Status changed from active, no longer recruiting to completed.
- 12 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 20 Feb 2015 New trial record